https://pmc.ncbi.nlm.nih.gov/articles/PMC10986562/
. 2024 Mar 14;12(4):e01653-23. doi: 10.1128/spectrum.01653-23
Vector-borne infections may underlie some rheumatic diseases, particularly in people with joint effusions. This study aimed to compare serum and synovial fluid antibodies to B. burgdorferi and Bartonella spp. in patients with rheumatic diseases. This observational, cross-sectional study examined paired synovial fluid and serum specimens collected from 110 patients with joint effusion between October 2017 and January 2022. Testing for antibodies to B. burgdorferi (using CDC criteria) and Bartonella spp. via two indirect fluorescent antibody (IFA) assays was performed as part of routine patient care at the Institute for Specialized Medicine (San Diego, CA, USA). There were 30 participants (27%) with positive two-tier B. burgdorferi serology and 26 participants (24%) with IFA seroreactivity (≥1:256) to B. henselae and/or B. quintana. Both B. burgdorferi IgM and IgG were detected more frequently in synovial fluid than serum: 27% of patients were either IgM or IgG positive in synovial fluid, compared to 15.5% in serum (P = 0.048). Conversely, B. henselae and B. quintana antibodies were detected more frequently in serum than synovial fluid; overall only 2% of patients had positive IFA titers in synovial fluid, compared to 24% who had positive IFA titers in serum (P < 0.001). There were no significant associations between B. burgdorferi or Bartonella spp. seroreactivity with any of the clinical rheumatological diagnoses. This study provides preliminary support for the importance of synovial fluid antibody testing for documenting exposure to B. burgdorferi but not for documenting exposure to Bartonella spp.
https://danielcameronmd.com/what-do-i-do-when-specialists-disagree/
Synovectomy for Lyme Arthritis
She had been ill for nearly two years when synovectomy for Lyme arthritis was recommended.
Her knee remained swollen, painful, and limiting despite treatment for Lyme arthritis. She had completed antibiotic therapy. When the swelling persisted, she was told the infection had been treated and what remained was inflammation.
Surgery was presented as the next step.
What was not discussed was how limited the supporting evidence actually is.
What Synovectomy Does—and Does Not Do
A synovectomy removes inflamed synovial tissue, most commonly from the knee. In some inflammatory arthritides, this can reduce swelling and improve joint function.
In synovectomy for Lyme arthritis, the procedure addresses local joint inflammation only. It does not treat Lyme disease systemically and has not been shown to prevent persistent or recurrent tick-borne infection in other organs.
The Evidence Supporting Synovectomy for Lyme Arthritis
The evidence supporting synovectomy for Lyme arthritis is narrow.
It rests primarily on a small case series published more than three decades ago involving patients with persistent knee effusions after antibiotic therapy. There are no large contemporary trials and no studies demonstrating that synovectomy alters the overall course of Lyme disease or prevents disease persistence outside the joint.
This context should be part of informed consent—but often isn’t.
Symptoms Beyond the Joint
Although the treatment plan focused on her knee, her illness extended beyond a single joint.
She experienced fatigue, cognitive slowing, and generalized symptoms that did not fit neatly into a surgical framework. These symptoms were not addressed in surgical discussions, despite their impact on daily function.
What Happened After Delay
After a period of delay, she was retreated medically.
Her improvement was gradual but meaningful. Over time, systemic symptoms eased and function improved—despite the prolonged course and delayed intervention.
Clinical Experience with Complex Lyme Arthritis Cases
In my practice, I see patients who have been told their joint inflammation is purely post-infectious, even when systemic symptoms suggest a broader process. Synovectomy may help select patients with truly isolated, refractory synovitis. But when symptoms extend beyond the joint, a careful re-evaluation—and, in some cases, medical retreatment—can be more clinically meaningful than focusing solely on tissue removal.
The decision should be based on the whole patient, not just the inflamed joint.
What Was Missing
A complete discussion would have made clear that synovectomy is a procedure aimed at reducing local joint inflammation, not at treating Lyme disease itself. It would have acknowledged that surgery has not been shown to prevent persistent or recurrent tick-borne infection elsewhere in the body, including the nervous system or other organs.
It also would have explained that the evidence supporting synovectomy in Lyme arthritis is limited, based largely on a small, decades-old case series rather than modern comparative trials. Importantly, it would have emphasized that even after prolonged symptoms, other medical options may still be appropriate, particularly when the clinical picture extends beyond a single joint.
Without this context—without an honest discussion of what is known, what is uncertain, and what alternatives remain—patients cannot fully understand their choices. And without that understanding, consent cannot truly be considered informed.
❓ Common Questions Patients Ask About Synovectomy for Lyme Arthritis
Does synovectomy cure Lyme disease?
No. Synovectomy does not cure Lyme disease. It removes inflamed tissue from a joint but does not treat infection elsewhere in the body.
Is there strong scientific evidence supporting synovectomy for Lyme arthritis?
No. The evidence is limited and largely based on a small case series published in the early 1990s. There are no modern randomized trials.
Can synovectomy prevent persistent Lyme infection in other organs?
No studies have shown that synovectomy prevents persistent or recurrent tick-borne infection in the nervous system, heart, or other tissues.
🩺 Clinician Perspective
Most patients with Lyme arthritis improve with antibiotics. A smaller subset develops persistent joint inflammation. In carefully selected cases, synovectomy may reduce localized synovitis.
However, the evidence remains limited, and the procedure has not been shown to alter systemic Lyme disease or prevent persistent infection in other tissues. Ethical care requires that these limits be disclosed as part of informed consent.
Resources
- Lochhead RB, et al. Post-infectious Lyme arthritis and immune-mediated synovitis. Clin Rev Allergy Immunol.
- Schoen RT, et al. Arthroscopic synovectomy in antibiotic-refractory Lyme arthritis. Arthritis Rheum. 1991.
- CDC. Signs and Symptoms of Untreated Lyme Disease
- Dr. Daniel Cameron: Lyme Science Blog. Signs and symptoms of Lyme disease
- Dr. Daniel Cameron: Lyme Science Blog. Lyme Disease Symptoms
______________
For more:
- https://madisonarealymesupportgroup.com/2022/12/20/lyme-arthritis-with-rheumatoid-arthritis-leads-to-poor-quality-of-life/
- https://madisonarealymesupportgroup.com/2022/05/04/why-do-some-people-develop-severe-lyme-arthritis-others-dont/
- https://madisonarealymesupportgroup.com/2022/10/12/seeking-to-unlock-the-mysteries-of-lyme-arthritis/
- https://madisonarealymesupportgroup.com/2023/01/05/lyme-arthritis-symptoms-in-young-child-emerge-years-after-tick-bite/
- https://madisonarealymesupportgroup.com/2023/10/10/lyme-disease-misdiagnosed-as-psoriatic-arthritis/
- https://madisonarealymesupportgroup.com/2023/12/08/the-potential-benefits-of-proteolytic-enzymes-to-help-manage-rheumatoid-arthritis/
- https://madisonarealymesupportgroup.com/2022/03/10/lyme-disease-an-underdiagnosed-cause-of-mono-arthritis/ In the comment section of this article I give treatments that have helped me with this. I would also like to add a few things here: DIET for me has been huge. Eliminating gluten, sugar, alcohol, and some dairy (I seemingly can eat aged cheeses that are hard, as well as fatty 4% cottage cheese and whipping cream for coffee). This has been the most important change I’ve made. This change alone dropped my inflammation that was causing the pain and truthfully – getting to the core problem of inflammation should be our #1 goal as it drives all of these issues. I will also add this form of curcumin to try (I am not affiliated and receive no monies from this company but have simply noticed radical improvement in pain reduction): https://www.amazon.com/Integrative-Therapeutics-Theracurmin-Supplement-Bioavailable/dp Each cap is 300 mg. I took 1 cap twice a day spread out. I noticed immediate improvement.
Madison Area Lyme Support Group 